Compass Therapeutics CMPX
NASDAQ CMPX
$0.86 -0.04 (-4.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Gains from Sales and Divestitures (2021 - 2023)

Updated

Compass Therapeutics' Gains from Sales and Divestitures was -$1.27 million in Q1 2023, compared with -$1.57 million a year earlier.

Analysis

Compass Therapeutics (CMPX) Gains from Sales and Divestitures (2021 - 2023) Analysis & Trends

For FY2022, Gains from Sales and Divestitures at Compass Therapeutics came in at $70,000, up 66.7% from FY2021.

  • In earlier years, Gains from Sales and Divestitures was $42,000 in FY2021 and -$281,000 in FY2020.
  • Quarterly Gains from Sales and Divestitures has moved between -$1.57 million (Q1 2022) and $69,000 (Q2 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Compass Therapeutics 154.88 Mn 154.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -1.27 Mn
Jun 30, 2022 69,000.00
Mar 31, 2022 -1.57 Mn
Dec 31, 2021 -33,000.00
Sep 30, 2021 31,000.00
Mar 31, 2021 44,000.00
API Access

Compass Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CMPX&period=max&api_key=YOUR_API_KEY